Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorErasmus Medical Center

About this trial

The primary goal of the patient-led follow-up from home, is the improvement of quality of life and the reduction of stress in patients, while obtaining a more complete picture of their health status.

A series of assessments are performed in the home setting:

* Blood withdrawal for CEA determination * Quality of life questionnaires to assess both mental and physical symptoms * Vital parameters using a Smart Sensor

Eligibility criteria

Qualifiers

Age ≥ 21 years

Histologically confirmed colorectal adenocarcinoma without distant metastasis and treated with curative intent surgical resection less than 6 months ago

Scheduled or currently undergoing postoperative surveillance according to national guidelines

Written informed consent by the patient

Disqualifiers

Patients with a severely complicated postoperative course, needing in hospital follow- up longer than 6 months postoperatively

Patients enrolled in other studies that require strict adherence to any specific follow-up practice with regular imaging - yearly or more frequent - of the abdomen and/or thorax

Patients with comorbidity or other malignancy that requires imaging of the abdomen and/or thorax every year or more frequent

Patients with active implantable devices - e.g. pacemaker or implantable defibrillator

Trial design

Treatments tested in this trial

  • Home-based follow-up

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

Erasmus Medical Center

Lead sponsor

Lifesignals Inc.

Collaborator

YourBio Health

Collaborator

TU Delft

Collaborator

Amphia Hospital

Collaborator

Leiden University Medical Center (LUMC)

Collaborator

Franciscus Gasthuis & Vlietland (Hospital)

Collaborator